US Stock MarketDetailed Quotes
ADVM Adverum Biotechnologies
- 9.1900
- -0.2000-2.13%
Close Apr 26 16:00 ET
- 9.1900
- 0.00000.00%
Post 16:16 ET
190.74MMarket Cap-792P/E (TTM)
10.1000High9.1100Low798.70KVolume9.6000Open9.3900Pre Close7.54MTurnover6.82%Turnover RatioLossP/E (Static)20.75MShares29.700052wk High2.29P/B107.70MFloat Cap7.210052wk Low--Dividend TTM11.72MShs Float624.8000Historical High--Div YieldTTM10.54%Amplitude5.3100Historical Low9.4380Avg Price1Lot Size
Adverum Biotechnologies Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.90%-90.9M | -15.44%-21.33M | 24.82%-23.91M | 19.50%-23.25M | 22.53%-22.41M | -0.24%-108.09M | 28.43%-18.48M | -23.31%-31.81M | 14.85%-28.88M | -29.70%-28.93M |
| Net income from continuing operations | 24.18%-117.17M | 27.56%-23.71M | 18.06%-32.89M | 28.00%-31.51M | 23.35%-29.06M | -6.18%-154.54M | 4.86%-32.74M | -4.61%-40.13M | 1.29%-43.76M | -33.31%-37.91M |
| Operating gains losses | -59.02%50K | -266.67%-35K | ---- | ---- | ---- | --122K | --21K | --0 | ---- | ---- |
| Depreciation and amortization | -13.54%5.64M | -41.06%1.01M | -15.60%1.51M | -4.30%1.53M | 11.72%1.59M | 40.54%6.53M | 29.50%1.71M | 85.86%1.79M | 34.14%1.6M | 22.21%1.43M |
| Other non cash items | 396.68%13.03M | -22.52%819K | 1,042.40%5.58M | 361.21%5.18M | 39.85%1.45M | 10,592.00%2.62M | 887.85%1.06M | -1,060.78%-592K | 2,982.05%1.12M | 2,561.90%1.03M |
| Change In working capital | -152.48%-8.32M | -154.84%-3.68M | -176.92%-2.43M | -143.74%-2.21M | -99.68%3K | 290.18%15.85M | 195.90%6.71M | -27.91%3.16M | 942.27%5.06M | 130.18%927K |
| -Change in prepaid assets | -61.87%480K | -70.32%1.4M | -343.62%-1.7M | 88.07%-149K | 131.69%924K | 138.77%1.26M | 1,821.54%4.73M | 137.88%697K | -233.96%-1.25M | -127.99%-2.92M |
| -Change in payables and accrued expense | -667.14%-5.58M | -332.99%-4.06M | 99.26%-45K | -126.49%-1.35M | -147.39%-118K | -40.85%983K | 273.61%1.74M | -267.72%-6.11M | 2,702.75%5.1M | 121.48%249K |
| -Change in other current assets | ---- | ---- | -99.11%38K | 102.46%43K | 103.74%62K | ---- | ---- | 225.73%4.27M | -213.46%-1.75M | -1,156.06%-1.66M |
| -Change in other current liabilities | -123.68%-3.22M | ---- | ---- | ---- | ---- | 364.72%13.61M | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | -116.84%-725K | -125.58%-754K | -116.47%-865K | ---- | ---- | 239.24%4.31M | 442.39%2.95M | 1,146.22%5.25M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.90%-90.9M | -15.44%-21.33M | 24.82%-23.91M | 19.50%-23.25M | 22.53%-22.41M | -0.24%-108.09M | 28.43%-18.48M | -23.31%-31.81M | 14.85%-28.88M | -29.70%-28.93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -31.64%96.88M | -542.17%-9.88M | -25.32%18.2M | 118.07%67.02M | -74.48%21.53M | 80.06%141.72M | -90.65%2.23M | 132.74%24.37M | -18.64%30.74M | 1,182.61%84.38M |
| Net PPE purchase and sale | 93.16%-808K | -3.78%-192K | 39.93%-495K | 99.44%-36K | 98.06%-85K | 21.87%-11.82M | 95.75%-185K | 85.59%-824K | -76.34%-6.43M | -211.54%-4.37M |
| Net investment purchase and sale | -36.38%97.68M | -500.41%-9.69M | -25.80%18.69M | 80.42%67.06M | -75.64%21.62M | 63.63%153.54M | -91.43%2.42M | 55.61%25.19M | -10.28%37.17M | 1,011.83%88.76M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -31.64%96.88M | -542.17%-9.88M | -25.32%18.2M | 118.07%67.02M | -74.48%21.53M | 80.06%141.72M | -90.65%2.23M | 132.74%24.37M | -18.64%30.74M | 1,182.61%84.38M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -88.63%69K | -31.40%166K | -105K | -97.79%8K | 0 | -74.68%607K | -35.47%242K | 0 | -29.98%362K | -99.80%3K |
| Proceeds from stock option exercised by employees | -19.44%489K | 0.00%242K | --1K | -32.04%246K | --0 | -36.24%607K | -35.47%242K | --0 | -31.18%362K | -94.12%3K |
| Net other financing activities | ---420K | ---76K | ---106K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -88.63%69K | -31.40%166K | ---105K | -97.79%8K | --0 | -74.68%607K | -35.47%242K | --0 | -29.98%362K | -99.80%3K |
| Net cash flow | ||||||||||
| Beginning cash position | 93.29%70.93M | 24.25%108.02M | 20.62%113.84M | -23.98%70.06M | 93.29%70.93M | -42.14%36.7M | 127.25%86.93M | 76.13%94.37M | 87.30%92.16M | -42.14%36.7M |
| Current changes in cash | -82.35%6.04M | -94.01%-31.04M | 21.76%-5.82M | 1,873.94%43.78M | -101.59%-879K | 228.10%34.24M | -927.55%-16M | 51.46%-7.44M | -49.35%2.22M | 489.97%55.46M |
| End cash Position | 8.52%76.98M | 8.52%76.98M | 24.25%108.02M | 20.62%113.84M | -23.98%70.06M | 93.29%70.93M | 93.29%70.93M | 127.25%86.93M | 76.13%94.37M | 87.30%92.16M |
| Free cash flow | 23.52%-91.71M | -15.33%-21.52M | 25.20%-24.41M | 34.06%-23.29M | 32.45%-22.5M | 2.48%-119.91M | 38.14%-18.66M | -3.54%-32.63M | 5.99%-35.31M | -40.47%-33.3M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg